Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.

Abdelrahman Z, Li M, Wang X. · 2020

Read Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses. by Abdelrahman Z, Li M, Wang X. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7516028.txt.

Introduction

Abdelrahman, Li, and Wang compare SARS-CoV-2 with SARS-CoV, MERS-CoV, and influenza A viruses. The new virus caused a global health emergency. Open questions covered its origin, spread, severity, and risk factors.

The review sets the four respiratory viruses side by side. It weighs their origins and genomic features in turn. Transmission strength and disease-causing power get direct comparison. Receptor binding and host factors shape how sick patients get. Prevention, control, and treatment close the survey. The authors aim the work at health officials and medical experts. A clear view of kin viruses can help curb the new pandemic. Lessons from SARS, MERS, and flu frame what to expect from SARS-CoV-2.

Catalog record

CREATORAbdelrahman Z, Li M, Wang X.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE69 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7516028

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses By Zeinab Abdelrahman, Mengyuan Li, Xiaosheng Wang Published in: Frontiers in Immunology DOI: 10.3389/fimmu.2020.552909 ABSTRACT The 2019 novel coronavirus (SARS-CoV-2) pandemic has caused a global health emergency. The outbreak of this virus has raised a number of questions: What is SARS-CoV-2? How transmissible is SARS-CoV-2? How severely affected are patients infected with SARS-CoV-2? What are the risk factors for viral infection? What are the differences between this novel coronavirus and other coronaviruses? To answer these questions, we performed a comparative study of four pathogenic viruses that primarily attack the respiratory system and may cause death, namely, SARS-CoV-2, severe acute respiratory syndrome (SARS-CoV), Middle East respiratory syndrome (MERS-CoV), and influenza A viruses (H1N1 and H3N2 strains). This comparative study provides a critical evaluation of the origin, genomic features, transmission, and pathogenicity of these viruses. Because the coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 is ongoing, this evaluation may inform public health administrators and medical experts to aid in curbing the pandemic's progression. INTRODUCTION The 2019 novel coronavirus (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and influenza A viruses are major pathogens that primarily target the human respiratory system. Diseases associated with their infections vary from mild respiratory illness to acute pneumonia and even respiratory failure. Since 1918, the influenza A viruses have caused four pandemics. The first and most severe pandemic in recent history, known as “Spanish influenza,” occurred in 1918 and was caused by an H1N1 influenza A virus (IAV) strain (1). Approximately 500 million people were infected, and 50 million people died during this pandemic. The second pandemic, known as “Asian influenza,” occurred in 1957, was caused by an H2N2 IAV strain, and resulted in ~1.1 million deaths worldwide (2). The third pandemic, known as “Hong Kong flu,” occurred in 1968 and was caused by an H3N2 IAV strain, resulting in ~1 million deaths worldwide (3). The fourth pandemic was caused by the influenza A (H1N1) pdm09 virus, also known as the “novel influenza A virus,” and resulted in 151,700–575,400 deaths worldwide from 2009 to 2010 (4, 5). Since that time, the novel influenza A virus has continued to spread as a seasonal flu virus. From September 2019 to February 2020, this virus caused at least 34 million flu illnesses and 20,000 deaths. In November 2002, before the fourth influenza A pandemic, an epidemic caused by a betacoronavirus (SARS-CoV) and known as severe acute respiratory syndrome (SARS) began in South China and spread to 29 countries. The SARS outbreak caused ~8,000 infections and 774 deaths before it was contained in July 2003, with a case fatality rate (CFR) of 9.6% (the CFR was ~50% among patients 65 or older) (6). However, since 2004, there have not been any SARS cases reported anywhere in the world. In September 2012, Saudi Arabia reported the first case of Middle East respiratory syndrome (MERS), which was caused by another type of betacoronavirus (MERS-CoV). MERS-CoV spread to 27 countries and caused 2,519 infections and 866 deaths by January 2020, with a CFR of 34.4% (7). In December 2019, cases of the new coronavirus disease 2019 (COVID-19), caused by a new betacoronavirus (SARS-CoV-2), were first reported in Wuhan, China (8). These cases were characterized by acute pneumonia-associated symptoms, such as fever, dry cough, chills, shortness of breath, and muscle pain (9). The SARS-CoV-2 outbreak rapidly spread worldwide. It has infected more than 14 million individuals and resulted in more than 500,000 deaths as of 20 July 2020. In comparison with the other two coronaviruses, SARS-CoV-2 appears to be much more contagious and infectious; it has rapidly resulted in a pandemic constituting a global health emergency (Figures 1A–C). [Figure: General characteristics of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza A viruses. (A) Epidemics of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza A viruses. The timeline, natural reservoirs, total number of deaths, and symptoms of the patients infected with these viruses. (B) Cumulative numbers of cases and deaths caused by SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza A (during the last seasonal flu 2019–2020) viruses. Influenza A virus infected the most people, while SARS-CoV-2 caused the most deaths. (C) Case-fatality rate (CFR) of patients infected with SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza A (the last seasonal flu 2019–2020) viruses stratified by age.] To better understand the current COVID-19 pandemic caused by SARS-CoV-2, we have performed a comparative study between SARS-CoV-2 and past epidemic/pandemic viral infections that primarily affect the respiratory system: the influenza A viruses (H3N2 and H1N1 strains) and the two coronaviruses SARS-CoV and MERS-CoV. We have explored the genomic characteristics, transmission, reservoirs, and pathogenesis of these four pathogens. We have also considered the preventive and control measures conducted by the World Health Organization (WHO) against the spread of these pathogens. Additionally, we have elucidated how these viruses attack the immune system and the associated host immune system response. This comparative study will aid in informing public health administrators and medical experts on how to adequately distinguish between these viruses and identify the preventive and control measures recommended by the WHO against the spread of SARS-CoV-2. A brief comparison between the four pathogenic viruses, including their characteristics, pathogenesis, and transmission, is summarized in Table 1. [Table: General characteristics of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza A viruses.] TAXONOMY, STRUCTURE, AND GENOMIC PROPERTIES OF THE VIRUSES Influenza A Influenza A viruses that infect humans mainly consist of two strains (H1N1 and H3N2). Both strains are characterized as enveloped, negative-sense, single-stranded RNA viruses with a total genome size of ~13.5 kb (18, 19). The influenza A virus genome consists of eight different segments, with each segment containing a region that encodes one or two proteins with specific functions, including hemagglutinin (HA), polymerase basic protein 2 (PB2), nucleoprotein (NP), polymerase basic protein 1 (PB1), neuraminidase (NA), matrix (M), nonstructural protein (NS1), and polymerase acidic protein (PA) (20, 21). The HA protein of influenza A viruses binds to the glycoprotein terminal sialic acid and glycolipid receptors, which contain α-2,6 and α-2,3 sialic acid groups attached to galactose. Although HA is considered to be a more crucial antigenic determinant than NA, both proteins are potentially restrictive factors for viral evolution (20, 22). In addition, there are three viral polymerase proteins, PB1, PB2, and PA, encoded on segments 1, 2, and 3, respectively; these polymerase proteins form an enzyme complex that plays a role in transcription and replication. Finally, the NP protein encoded on segment 5 is used as a model to generate additional copies (23, 24). Influenza A viruses exhibit antigenic drift/shift properties, allowing them to avoid the host immune response. The Centers for Disease Control and Prevention (CDC) defines antigenic drift as genetic variation that occurs in antigen structures owing to point mutations in the HA and NA genes over time, whereas antigenic shift is the result of a sudden genetic reassortment between two or more closely related influenza viral strains (23, 24). A well-known example of the antigenic shift phenomenon is the triple reassortment that occurred in the influenza A pdm09 virus and caused the 2009 pandemic as a result of the replacement of the hemagglutinin H2 and polymerase PB1 genes of the avian H2N2 virus with two new

Read the complete text